This isn’t an argument towards capital in unbiased medication. Practices want infrastructure, and physicians have professional causes to hunt liquidity. It’s an argument that the exit stage carries a danger this market has not but priced.
The put up What Occurs to Impartial Drugs When Personal Fairness Reveals Up With a Checkbook appeared first on MedCity Information.
